Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China YCT International Group to Hold its Annual Meeting of Stockholders on October 8, 2018 Beijing Time 2018-08-28 04:47
China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement 2018-08-24 20:00
Bridge Biotherapeutics Presented Preclinical Study Results on BBT-877, an Autotaxin inhibitor at the IPF Summit 2018 2018-08-23 06:00
China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal 2018-08-21 20:00
Shineco, Inc. Enters into Strategic Cooperation Agreement with the People's Government of Bayingolin Mongol Autonomous Prefecture for Apocynum Industrial Integration Construction Project 2018-08-20 21:30
Shanghai ChemPartner Announces Merger Deal Closure with Quantum 2018-08-17 00:42
China YCT International Group Reports Financial Results for the Fiscal Quarter Ended June 30, 2018 2018-08-15 04:15
China Biologic Names Bing Li as New CEO 2018-08-13 20:00
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China 2018-08-09 17:05
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round 2018-08-08 19:00
VolitionRx Announces $9 Million Private Placement 2018-08-08 18:00
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202 2018-08-08 09:01
Ward MM and Adapt Analytics announce a partnership to integrate AI and machine learning into Ward MM's clinical decision support engine 2018-08-07 21:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
IMPACT Therapeutics Raises $30 Million In Series C Financing 2018-08-03 16:48
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA 2018-08-01 18:52
I-Mab Biopharma Announces New CFO 2018-08-01 08:44
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
1 131 132 133 134 135 158